184 related articles for article (PubMed ID: 14983941)
1. Bone marrow biopsies for the diagnosis of systemic mastocytosis: is one biopsy sufficient?
Butterfield JH; Li CY
Am J Clin Pathol; 2004 Feb; 121(2):264-7. PubMed ID: 14983941
[TBL] [Abstract][Full Text] [Related]
2. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
[TBL] [Abstract][Full Text] [Related]
3. Biochemical markers predictive for bone marrow involvement in systemic mastocytosis.
Donker ML; van Doormaal JJ; van Doormaal FF; Kluin PM; van der Veer E; de Monchy JG; Kema IP; Kluin-Nelemans HC
Haematologica; 2008 Jan; 93(1):120-3. PubMed ID: 18166795
[TBL] [Abstract][Full Text] [Related]
4. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis.
Hahn HP; Hornick JL
Am J Surg Pathol; 2007 Nov; 31(11):1669-76. PubMed ID: 18059223
[TBL] [Abstract][Full Text] [Related]
5. Current approaches to the diagnosis and treatment of systemic mastocytosis.
Bains SN; Hsieh FH
Ann Allergy Asthma Immunol; 2010 Jan; 104(1):1-10; quiz 10-2, 41. PubMed ID: 20143640
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous manifestations in Hymenoptera and Diptera anaphylaxis: relationship with basal serum tryptase.
Potier A; Lavigne C; Chappard D; Verret JL; Chevailler A; Nicolie B; Drouet M
Clin Exp Allergy; 2009 May; 39(5):717-25. PubMed ID: 19302252
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow tryptase as a possible diagnostic criterion for adult systemic mastocytosis.
Bulai Livideanu C; Apoil PA; Lepage B; Eischen M; Laurent C; Laharrague P; Lamant L; Tournier E; Tavitian S; Pouplard C; Recher C; Laroche M; Mailhol C; Dubreuil P; Hermine O; Blancher A; Paul C
Clin Exp Allergy; 2016 Jan; 46(1):133-41. PubMed ID: 26767494
[TBL] [Abstract][Full Text] [Related]
8. Systemic mastocytosis: a diagnostic challenge.
Bateman HE; Shroff V; Centeno LV; Bielory L
Ann Allergy Asthma Immunol; 1995 May; 74(5):379-86. PubMed ID: 7749967
[TBL] [Abstract][Full Text] [Related]
9. [Sudden death in the presence of systemic mastocytosis and urticaria pigmentosa].
Wehner F; Wehner HD; Fritz P; Benz D; Schulz MM
Arch Kriminol; 2008; 222(5-6):187-94. PubMed ID: 19216369
[TBL] [Abstract][Full Text] [Related]
10. Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions.
van Doormaal JJ; van der Veer E; van Voorst Vader PC; Kluin PM; Mulder AB; van der Heide S; Arends S; Kluin-Nelemans JC; Oude Elberink JN; de Monchy JG
Allergy; 2012 May; 67(5):683-90. PubMed ID: 22435702
[TBL] [Abstract][Full Text] [Related]
11. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
12. [Systemic mastocytosis. Study of 14 cases].
García-Erce JA; Giraldo P; de Vicente P; Alvarez R; Losfablos F; Velilla J; Mayayo P; Rubio-Félix D; Giralt M
Med Clin (Barc); 1998 Oct; 111(13):499-502. PubMed ID: 9859067
[TBL] [Abstract][Full Text] [Related]
13. Diminished reliability of tryptase as risk indicator of mastocytosis in older overweight subjects.
Vos BJ; van der Veer E; van Voorst Vader PC; Mulder AB; van der Heide S; Arends S; Kluin-Nelemans JC; de Monchy JG; van Doormaal JJ; Oude Elberink JN
J Allergy Clin Immunol; 2015 Mar; 135(3):792-8. PubMed ID: 25129675
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of systemic mastocytosis with high-dose interferon-alfa: long-term follow-up of a case.
Butterfield JH; Tefferi A; Kozuh GF
Leuk Res; 2005 Feb; 29(2):131-4. PubMed ID: 15607359
[TBL] [Abstract][Full Text] [Related]
15. Audit of bone marrow aspirates and trephine biopsies in multiple myeloma--a single centre study.
Charles KS; Winfield DA; Angel C; Goepel J
Clin Lab Haematol; 2004 Dec; 26(6):403-6. PubMed ID: 15595998
[TBL] [Abstract][Full Text] [Related]
16. Systemic mastocytosis: a rare cause of noncirrhotic portal hypertension simulating autoimmune cholangitis--report of four cases.
Kyriakou D; Kouroumalis E; Konsolas J; Oekonomaki H; Tzardi M; Kanavaros P; Manoussos O; Eliopoulos GD
Am J Gastroenterol; 1998 Jan; 93(1):106-8. PubMed ID: 9448186
[TBL] [Abstract][Full Text] [Related]
17. IL-6 levels predict disease variant and extent of organ involvement in patients with mastocytosis.
Brockow K; Akin C; Huber M; Metcalfe DD
Clin Immunol; 2005 May; 115(2):216-23. PubMed ID: 15885646
[TBL] [Abstract][Full Text] [Related]
18. Adult mastocytosis: a review of the Santo António Hospital 's experience and an evaluation of World Health Organization criteria for the diagnosis of systemic disease.
Fernandes IC; Teixeira Mdos A; Freitas I; Selores M; Alves R; Lima M
An Bras Dermatol; 2014; 89(1):59-66. PubMed ID: 24626649
[TBL] [Abstract][Full Text] [Related]
19. Systemic mastocytosis: current concepts and treatment advances.
Tefferi A; Pardanani A
Curr Hematol Rep; 2004 May; 3(3):197-202. PubMed ID: 15087068
[TBL] [Abstract][Full Text] [Related]
20. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.
Butterfield JH; Weiler CR
Int Arch Allergy Immunol; 2008; 147(4):338-43. PubMed ID: 18622141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]